AI Multiomics Aging Platform

About AgeCurve

AgeCurve is a private, pre-clinical stage biotech leveraging artificial intelligence and single-cell multiomics to map the biological mechanisms of aging. Its core platform analyzes somatic mutations and cellular phenotypes to create a 'cell tree ring' model of aging, with the goal of identifying novel drug targets and optimizing treatments at an individual level. The company appears to be in an early R&D and platform validation phase, supported by investors and partners, and has published initial research in the field of geroscience. Its business model is focused on developing both therapeutics and diagnostics from its proprietary AI platform.

Therapeutic Areas